Skip to main content

Table 1 Inclusion and exclusion criteria

From: Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis

Inclusion criteria Exclusion criteria
• Written informed consent • Missing written informed consent
• Histologically confirmed, primary or locally recurrent soft tissue sarcoma of the retroperitoneal space • Missing histological conformation of soft tissue sarcoma
• Judged as at least marginally resectable • Desmoid Tumors (aggressive fibromatosis), Gastrointestinal Stroma Tumors (GIST)
• Absence of distant metastases • Judged as gross incomplete or not resectable
• Tumor size ≥ 5 cm • Incomplete staging
• Presence of distant metastases
• Prior radiation therapy to the abdominal region
• Participation in another clinical interventional study
• Inflammatory bowel disease
\